Efficient development of Plasmodium liver stage-specific memory CD8 + T cells during the course of blood-stage malarial infection

Journal of Infectious Diseases

Volumn 196, Issue 12, 2007, Pages 1827-1835

  Hafalla, Julius C R ^a,b   Rai, Urvashi ^a   Bernal Rubio, Dabeiba ^a,d   Rodriguez, Ana ^a   Zavala, Fidel ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FLOW CYTOMETRY; LIVER CELL; MALARIA; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PARASITEMIA; PHENOTYPE; PLASMODIUM YOELII; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPOROZOITE; ANIMAL; ANOPHELES; BAGG ALBINO MOUSE; BLOOD; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LIVER; PARASITOLOGY; RADIATION EXPOSURE; VACCINIA VIRUS;

EPITOPE; MALARIA VACCINE;

ANIMALS; ANOPHELES; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNOLOGIC MEMORY; LIVER; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PLASMODIUM YOELII; SPOROZOITES; VACCINIA VIRUS;

EID: 39149095964     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522965     Document Type: Article

References (39)

1. Nussenzweig V, Nussenzweig RS. Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol 1989; 45:283-334.
2. Tsuji M, Zavala F. T cells as mediators of protective immunity against liver stages of Plasmodium. Trends Parasitol 2003; 19:88-93.
3. + T cell responses to malaria liver stages. Proc Natl Acad Sci USA 2002; 99:11819-24.
4. Wilson NS, Behrens GM, Lundie RJ, et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol 2006; 7:165-72.
5. Seixas E, Cross C, Quin S, Langhorne J. Direct activation of dendritic cells by the malaria parasite, Plasmodium chabaudi chabaudi. Eur J Immunol 2001; 31:2970-8.
6. Sponaas AM, Cadman ET, Voisine C, et al. Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells. J Exp Med 2006; 203:1427-33.
7. Perry JA, Rush A, Wilson RJ, Olver CS, Avery AC. Dendritic cells from malaria-infected mice are fully functional APC. J Immunol 2004; 172: 475-82.
8. Urban BC, Ferguson DJ, Pain A, et al. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 1999; 400:73-7.
9. Ocana-Morgner C, Mota MM, Rodriguez A. Malaria blood stage suppression of liver stage immunity by dendritic cells. J Exp Med 2003; 197: 143-51.
10. Millington OR, Di Lorenzo C, Phillips RS, Garside P, Brewer JM. Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J Biol 2006; 5:5.
11. + T cells against malaria liver stages. J Exp Med 2001; 194:173-80.
12. Hafalla JC, Rai U, Morrot A, Bernal-Rubio D, Zavala F, Rodriguez A. Priming of CD8+ T cell responses following immunization with heat-killed Plasmodium sporozoites. Eur J Immunol 2006; 36:1179-86.
13. Li S, Rodrigues M, Rodriguez D, et al. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci USA 1993; 90:5214-8.
14. Hafalla JC, Morrot A, Sano G, Milon G, Lafaille JJ, Zavala F. Early self-regulatory mechanisms control the magnitude of CD8+ T cell responses against liver stages of murine malaria. J Immunol 2003; 171:964-70.
15. Rodrigues M, Li S, Murata K, et al. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. J Immunol 1994; 153:4636-48.
16. + T cell responses. J Immunol Methods 2001; 252: 207-18.
17. Goossens PL, Jouin H, Marchal G, Milon G. Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver. J Immunol Methods 1990; 132:137-44.
18. Bruna-Romero O, Hafalla JC, Gonzalez-Aseguinolaza G, Sano G, Tsuji M, Zavala F. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. Int J Parasitol 2001; 31:1499-502.
19. Miyahira Y, Murata K, Rodriguez D, et al. Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J Immunol Methods 1995; 181:45-54.
20. Kaech SM, Hemby S, Kersh E, Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 2002; 111:837-51.
21. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
22. Wherry EJ, Teichgraber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003; 4:225-34.
23. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291:2413-7.
24. Morrot A, Hafalla JC, Cockburn IA, Carvalho LH, Zavala F. IL-4 receptor expression on CD8+ T cells is required for the development of protective memory responses against liver stages of malaria parasites. J Exp Med 2005; 202:551-60.
25. Bruna-Romero O, Gonzalez-Aseguinolaza G, Hafalla JC, Tsuji M, Nussenzweig RS. Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen. Proc Natl Acad Sci USA 2001; 98:11491-6.
26. Murata K, Garcia-Sastre A, Tsuji M, et al. Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cell Immunol 1996; 173:96-107.
27. + T cells. Virology 2001; 280: 155-9.
28. Dunachie SJ, Hill AV. Prime-boost strategies for malaria vaccine development. J Exp Biol 2003; 206:3771-9.
29. Li S, Locke E, Bruder J, et al. Viral vectors for malaria vaccine development. Vaccine 2007; 25:2567-74.
30. Moorthy VS, Pinder M, Reece WH, et al. Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults. J Infect Dis 2003; 188:1239-44.
31. Braga EM, Carvalho LH, Fontes CJ, Krettli AU. Low cellular response in vitro among subjects with long-term exposure to malaria transmission in Brazilian endemic areas. Am J Trop Med Hyg 2002; 66:299-303.
32. Doolan DL, Khamboonruang C, Beck HP, Houghten RA, Good MF. Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants. Int Immunol 1993; 5:37-46.
33. Plebanski M, Aidoo M, Whittle HC, Hill AV. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. J Immunol 1997; 158:2849-55.
34. Reece WH, Plebanski M, Akinwunmi P, et al. Naturally exposed populations differ in their T1 and T2 responses to the circumsporozoite protein of Plasmodium falciparum. Infect Immun 2002; 70:1468-74.
35. Suphavilai C, Looareesuwan S, Good MF. Analysis of circumsporozoite protein-specific immune responses following recent infection with Plasmodium vivax. Am J Trop Med Hyg 2004; 71:29-39.
36. Belnoue E, Costa FT, Frankenberg T, et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 2004; 172:2487-95.
37. Korten S, Anderson RJ, Hannan CM, et al. Invariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice. Infect Immun 2005; 73:849-58.
38. Harty JT, Tvinnereim AR, White DW. CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol 2000; 18:275-308.
39. Masopust D, Kaech SM, Wherry EJ, Ahmed R. The role of programming in memory T-cell development. Curr Opin Immunol 2004; 16:217-25.